Aldeyra Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,262.40
8,527.30
27,590.60
24,912.60
42,946.80
93,599.70
Other Current Assets
8.40
232.60
497.60
218.70
1,019.00
1,169.60
Total Current Assets
3,270.80
8,759.90
28,088.20
25,131.30
43,965.80
94,769.30
Net Property, Plant & Equipment
-
13.00
80.30
56.40
43.30
235.20
Other Assets
472.50
14.20
36.20
-
165.90
86.60
Total Assets
3,743.20
8,787.10
28,204.80
25,187.70
44,175.00
95,091.20
ST Debt & Current Portion LT Debt
145.30
77.50
77.50
77.50
116.30
Accounts Payable
341.90
-
-
-
1,001.00
Income Tax Payable
70.60
-
-
-
-
Other Current Liabilities
47.30
1,250.00
2,037.60
2,221.70
2,236.50
Total Current Liabilities
605.00
1,327.60
2,115.10
2,299.20
3,353.70
Long-Term Debt
4,647.90
1,175.50
1,211.30
1,238.60
1,220.20
Other Liabilities
394.40
-
-
-
-
Total Liabilities
5,647.30
2,503.00
3,326.40
3,537.90
4,573.90
Common Equity (Total)
40,221.30
6,284.10
24,878.30
21,649.80
39,601.00
Total Shareholders' Equity
1,904.00
6,284.10
24,878.30
21,649.80
39,601.00
Total Equity
1,904.00
6,284.10
24,878.30
21,649.80
39,601.00
Liabilities & Shareholders' Equity
3,743.20
8,787.10
28,204.80
25,187.70
44,175.00
Preferred Stock (Carrying Value)
38,317.30
-
-
-
-
About Aldeyra Therapeutics
View Profile
